health benefits of bpc 157 Peptide BPC-157 BPC-157: A Revolutionary Peptide Therapy

PubMed Wadden, T.A., Chao, A.M., Machineni, S., Kushner, R.F., Ard, J., Srivastava, G., et al

BPC-157 is a research peptide that has not been approved by Health Canada or the FDA for human therapeutic use

However, the trial is listed as canceled, which indicates the study sponsor or investigator recalled a submission of study results before quality control review took place

Don't have supplies

Dutta SK, Verma S, Jain V, Surapaneni BK, Vinayek R, Phillips L, Nair PP

Type 2 Diabetes With Obesity# Recommendation : CagriSema Reason : REDEFINE 2 showed 13.7% weight loss with 73.5% of T2D patients achieving HbA1c of 6.5% or less, exceeding semaglutide's glycemic and weight results in T2D trials